Courtney Marabella

Articles

Immunotherapy Regimen Continues to Improve GI Treatment

April 29, 2021

With immunotherapy options expanding for patients with a range of gastrointestinal cancers to include combination strategies with chemotherapy, their use in the treatment course should come sooner rather than later for those with high PD-L1 expression.

T-DM1 Toxicity Management in Breast Cancer

April 05, 2021

Data from the pivotal phase 3 KATHERINE has led to the addition of ado-trastuzumab emtansine to the HER2-positive breast cancer treatment arsenal, but the toxicities associated with the approach must be appropriately managed so that patients can continue to receive it.

OVAL Trial Gets the OK to Continue for Patients With Ovarian Cancer

February 27, 2021

An independent data safety monitoring committee has not observed any safety issues with the phase 3 OVAL trial examining VB-111 in patients with platinum-resistant ovarian cancer, and as such, has recommended that the trial continue as planned.

Prioritize Patients With Cancer for COVID-19 Vaccine, Orgs Say

February 19, 2021

Leading organizations, cancer centers, and other institutions sent a letter to President Joe Biden and his administration, as well as other leading public health officials at state health departments advocating for priority access to the COVID-19 vaccine for patients and survivors of cancer.